Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas

British Journal of Radiology

Volumn 84, Issue 1008, 2011, Pages 1083-1090

  Chatterjee, Sanjoy ^a   Willis, N ^a   Locks, S M ^a   Mott, J H ^a   Kelly, C G ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CONTROL; CANCER PATIENT; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; HEAD AND NECK CARCINOMA; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; PATIENT CARE PLANNING; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TOMOTHERAPY; TONGUE CARCINOMA;

ALGORITHMS; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; RADIOBIOLOGY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 82655176424     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/53812025     Document Type: Article

References (37)

1. Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008;72:589-96.
2. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 2007;29:387-400. (Pubitemid 46623504)
3. van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJ, Rasch CR. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41.
4. Rudat V, Münter M, Rades D, Grötz KA, Bajrovic A, Haberkorn U, et al. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol 2008;9:71-80.
5. Ortholan C, Chamorey E, Benezery K, Thariat J, Dassonville O, Poissonnet G, et al. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys 2009;73:178-86.
6. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 2001;61:275-80. (Pubitemid 33127232)
7. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007;29:211-20. (Pubitemid 46339317)
8. Saarilahti K, Kouri M, Collan J, Hämäläinen T, Atula T, Joensuu H, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 2005;74:251-8. (Pubitemid 40349134)
9. Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G, et al. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:1252-9.
10. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704. (Pubitemid 32515326)
11. Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;66:966-74. (Pubitemid 44633520)
12. Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008;118:635-9. (Pubitemid 351496757)
13. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009;74:1-8.
14. Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California - San Francisco experience. Cancer 2008;113:497-507.
15. Mackie TR. History of tomotherapy. Phys Med Biol 2006;51:R427-53. (Pubitemid 43958627)
16. Beavis AW. Is tomotherapy the future of IMRT? Br J Radiol 2004;77:285-95. (Pubitemid 38579112)
17. Sheng K, Molloy JA, Read PW. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys 2006;65:917-23. (Pubitemid 43795846)
18. van Vulpen M, Field C, Raaijmakers CP, Parliament MB, Terhaard CH, MacKenzie MA, et al. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;62:1535-9. (Pubitemid 40982080)
19. Murthy V, Gupta T, Kadam A, Ghosh-Laskar S, Budrukkar A, Phurailatpam R, et al. Time trial: a prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers. J Cancer Res Ther 2009;5:107-12.
20. Chatterjee S, Mott JH, Smyth G, Dickson S, Kelly GC. Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre. Br J Radiol 2011,84:358-66.
21. Mackie T, Balog J, Ruchala K, Shepard D, Aldridge S, Fitchard E, et al. Tomotherapy. Semin Radiat Oncol 1999;9:108-117. (Pubitemid 29096027)
22. Mackie TR, Kapatoes J, Ruchala K, Lu W, Wu C, Olivera G, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:89-105. (Pubitemid 36403680)
23. Sanchez-Nieto B, Nahum AE. BIOPLAN: software for the biological evaluation of radiotherapy treatment plans. Med Dosim 2000;25:71-6. (Pubitemid 30336646)
24. Emami B, Lyman J, Brown A, Coia L,GoiteinM, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
25. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
26. Bentzen SM, Thames HD. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 1996;36:247-51. (Pubitemid 26314173)
27. Webb S, Evans PM, Swindell W, Deasy JO. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume. Phys Med Biol 1994;39:2091-8. (Pubitemid 24342702)
28. UK Clinical ResearchNetwork: Portfolio Database. [Cited Jan. 4, 2010] MREC No: 08/H0907/127, UKCRN ID 7341. Chatterjee S (Chief investigator). VortigERN: variation of radiotherapy target volume definition, dose to organs at risk (OAR) and clinical target volumes using anatomic (CT) vs. combined anatomic and molecular imaging (PET-CT): intensity modulated radiotherapy delivered using a tomotherapy Hi Art machine. Available from: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID57341.
29. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64:333-42.
30. Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007;85:36-41. (Pubitemid 47570062)
31. Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus helical tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 2007;82:174-8. (Pubitemid 46275139)
32. Longobardi B, De Martin E, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Radiother Oncol 2005;77:148-56. (Pubitemid 41682380)
33. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-8. (Pubitemid 36403679)
34. Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, et al. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 2008;70:908-15. (Pubitemid 351199725)
35. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76:S10-9.
36. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010;76:S3-9.
37. Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010;76:S58-63.